Offer - Urjas Oil for just ₹ 1 X
Itact is a prescription drug, available for use as Injection. Primarily, it is used for the treatment of Neutropenia.
Medical history of the patient along with age and gender determines the dosage of Itact. Individual symptoms and route of administration also determines the right dosage. Detailed information has been provided in the dosage section.
Besides the aforementioned side effects, there are other adverse effects of Itact as well, which are listed below. Usually, these side effects of Itact go away soon, and do not persist beyond the duration of the treatment. Please speak with your doctor if these side effects worsen or persist for a longer duration.
Itact's effect during pregnancy is Moderate and Moderate while nursing. It is important to know if Itact has any effect on the kidney, liver and heart. Information on such adverse effects, if any, has been given in the Itact related warnings section.
Itact is not recommended if you suffer from certain medical conditions as it can have adverse effects. Blood Cancer are examples of such conditions. Other contraindications of Itact have been discussed in the sections ahead.
Besides this, Itact may also have severe interaction with some medicines. A complete list of these interactions is given below.
You should also be aware that Itact is safe while driving, and is addiction.
Itact is used to treat the following -
Other Benefits
This is the usual dosage recommended in most common treatment cases. Please remember that every patient and their case is different, so the dosage can be different based on the disease, route of administration, patient's age and medical history.
Find the right dosage based on disease and age
Age Group | Dosage |
Adult |
|
Geriatric |
|
13 - 18 years (Adolescent) |
|
2 - 12 years (Child) |
|
Infant (1 month to 2 years) |
|
Is the use of Itact safe for pregnant women?
Itact can have harmful effects in pregnant women. If you experience any discomfort after using Itact, then discontinue the use and take your doctor's advice.
Is the use of Itact safe during breastfeeding?
Itact may lead to some side effects in breastfeeding women. If you witness any unusal symptoms after taking Itact, discontinue its use and call your doctor right away. Follow your doctor's advice regarding the use of Itact.
What is the effect of Itact on the Kidneys?
Itact rarely affects the kidneys.
What is the effect of Itact on the Liver?
Side effects of Itact rarely affect the liver.
What is the effect of Itact on the Heart?
You may experience side effects on your heart after taking Itact. If this happens, then discontinue its use. Consult your medical practitioner, and do as he/she suggests.
Itact should not be taken with following medicines due to severe side effects it may cause to patients -
Severe
Moderate
If you are suffering from any of the following diseases, you should not take Itact unless your doctor advises you to do so -
Is this Itact habit forming or addictive?
No, there is no any evidence that Itact is addictive.
Is it safe to drive or operate heavy machinery when consuming?
Yes, you can comfortably use machinery or drive after taking Itact since it will not make you feel sleepy.
Is it safe?
Yes, but consume Itact only on doctor's advice.
Is it able to treat mental disorders?
No, the use of Itact in mental disorders is not effective.
Interaction between Food and Itact
There isn't any research available on the side effects of taking Itact with food.
Interaction between Alcohol and Itact
No research has been done on this till date. Therefore, it is not known what the effect of taking Itact with alcohol will be.
This medicine data has been created by -
B.Pharma, Pharmacy
5 Years of Experience
References
US Food and Drug Administration (FDA) [Internet]. Maryland. USA; Package leaflet information for the user; Neupogen® (Filgrastim)
KD Tripathi. [link]. Seventh Edition. New Delhi, India: Jaypee Brothers Medical Publishers; 2013: Page No 876
April Hazard Vallerand, Cynthia A. Sanoski. [link]. Sixteenth Edition. Philadelphia, China: F. A. Davis Company; 2019: Page No 567-560